FDA's Overreach on Compounded Peptides FDA moves toward easing restrictions on certain peptides BioPharma Dive Understanding the Legal Risks of BPC 157 and Other Unapproved Peptides Holt Law The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York What are peptides? The treatments promising weight loss and better skin, explained Vox